98 related articles for article (PubMed ID: 10530385)
21. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors.
Watts VJ; Neve KA
Pharmacol Ther; 2005 Jun; 106(3):405-21. PubMed ID: 15922020
[TBL] [Abstract][Full Text] [Related]
22. Adenylate and guanylate cyclase activities in isolated guinea pig epidermal cells at various stages of differentiation.
Takigawa M; Yamada M; Taniguchi S; Imamura S
Acta Derm Venereol; 1988; 68(1):27-32. PubMed ID: 2449008
[TBL] [Abstract][Full Text] [Related]
23. [Cyclase system and lysosomal enzyme activity in normal and pathological states].
Korovkin BF
Vestn Akad Med Nauk SSSR; 1982; (9):69-74. PubMed ID: 6128842
[No Abstract] [Full Text] [Related]
24. Diabetes reduces right atrial beta-adrenergic signaling but not agonist stimulation of heart rate in swine.
Stanley WC; Dore JJ; Hall JL; Hamilton CD; Pizzurro RD; Roth DA
Can J Physiol Pharmacol; 2001 Apr; 79(4):346-51. PubMed ID: 11332512
[TBL] [Abstract][Full Text] [Related]
25. Chronic but not acute intracerebroventricular administration of amyloid beta-peptide(25-35) decreases somatostatin content, adenylate cyclase activity, somatostatin-induced inhibition of adenylate cyclase activity, and adenylate cyclase I levels in the rat hippocampus.
Burgos-Ramos E; Hervás-Aguilar A; Puebla-Jiménez L; Boyano-Adánez MC; Arilla-Ferreiro E
J Neurosci Res; 2007 Feb; 85(2):433-42. PubMed ID: 17086550
[TBL] [Abstract][Full Text] [Related]
26. Persistent activation of Gsalpha through limited proteolysis by calpain.
Sato-Kusubata K; Yajima Y; Kawashima S
Biochem J; 2000 May; 347 Pt 3(Pt 3):733-40. PubMed ID: 10769177
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study of molecular mechanisms of natural and synthetic polycationic peptides action on the activity of the adenylyl cyclase signaling system].
Shpakov AO; Gur'ianov IA; Kuznetsova LA; Plesneva SA; Zakharova ET; Vlasov GP; Pertseva MN
Tsitologiia; 2006; 48(5):450-9. PubMed ID: 16892855
[TBL] [Abstract][Full Text] [Related]
28. Guanylate cyclase activity in heart and lung.
White AA
Adv Cyclic Nucleotide Res; 1975; 5():353-73. PubMed ID: 236642
[No Abstract] [Full Text] [Related]
29. Subcellular localization of cardiac adenylate cyclase: sarcolemma or sarcoplasmic reticulum?
Jones LR; Besch HR; Watanabe AM
Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():227-34. PubMed ID: 1031927
[No Abstract] [Full Text] [Related]
30. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
31. Adenylate cyclase activity and localization in necrotic and non-necrotic areas of rat myocardium after injection of high doses of isoproterenol.
Schulze W; Ostadal B; Pelouch V
Biomed Biochim Acta; 1984; 43(1):67-75. PubMed ID: 6721878
[TBL] [Abstract][Full Text] [Related]
32. Association of adenylate cyclase inhibition by NaF with loss of a factor in rat heart sarcolemma.
Michiel DF; Lamers JM; Panagia V; Dhalla NS
Biochem Biophys Res Commun; 1983 Sep; 115(2):583-9. PubMed ID: 6626205
[TBL] [Abstract][Full Text] [Related]
33. Novel regulatory properties of human type 9 adenylate cyclase.
Cumbay MG; Watts VJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):108-15. PubMed ID: 14996950
[TBL] [Abstract][Full Text] [Related]
34. Intracellular actions of 5-hydroxytryptamine on the bivalve myocardium. 1. Adenylate and guanylate cyclases.
Higgins WJ
J Exp Zool; 1974 Oct; 190(1):99-110. PubMed ID: 4154964
[No Abstract] [Full Text] [Related]
35. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide attenuates alpha(2)-adrenergic receptors by ADP-ribosylation of G(i)alpha in ciliary epithelium.
Moroi SE; Hao Y; Sitaramayya A
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2056-62. PubMed ID: 11481272
[TBL] [Abstract][Full Text] [Related]
37. Different modulation of inhibitory and stimulatory pathways mediated by adenosine after chronic in vivo agonist exposure.
Ruiz MA; Albasanz JL; León D; Ros M; Andrés A; Martín M
Brain Res; 2005 Jan; 1031(2):211-21. PubMed ID: 15649446
[TBL] [Abstract][Full Text] [Related]
38. [Molecular causes of changes in sensitivity of adenylyl cyclase signaling system to biogenic amines in the heart muscle during experimental streptozotocin diabetes].
Shpakov AO; Kuznetsova LA; Plesneva SA; Gur'ianov IA; Pertseva MN
Tsitologiia; 2005; 47(6):540-8. PubMed ID: 16708847
[TBL] [Abstract][Full Text] [Related]
39. The role of Gi proteins in reduced vasorelaxation response to beta-adrenoceptor agonists in rat aorta during maturation.
Baloğlu E; Kiziltepe O; Gürdal H
Eur J Pharmacol; 2007 Jun; 564(1-3):167-73. PubMed ID: 17395174
[TBL] [Abstract][Full Text] [Related]
40. Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes.
Fenton RA; Dobson JG
J Cell Physiol; 2007 Dec; 213(3):785-92. PubMed ID: 17516542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
